ArticleCancer drug resistance (Alhambra, Calif.)2020

Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?

Carl Christofer JuhlinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.